| |
|
|
|
|
|
|
|||
|
Blood, 28 May 2009, Vol. 113, No. 22, pp. 5466-5475. Prepublished online as a Blood First Edition Paper on April 3, 2009; DOI 10.1182/blood-2008-09-179747.
Submitted September 16, 2008
Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States * Corresponding author; email: lee.grimes{at}cchmc.org.
In severe congenital neutropenia (SCN) patients and mice with Growth factor independent-1 (Gfi1) loss of function, arrested myeloid progenitors accumulate while terminal granulopoiesis is blocked. One might assume that Gfi1 null progenitors accumulate because they lack the ability to differentiate. Instead, our data indicate that Gfi1 loss of function deregulates two separable transcriptional programs, one of which controls the accumulation and lineage specification of myeloid progenitors, but not terminal granulopoiesis. We demonstrate that Gfi1 directly represses HoxA9, Pbx1 and Meis1 during normal myelopoiesis. Gfi1-/- progenitors exhibit elevated levels of HoxA9, Pbx1 and Meis1, exaggerated HoxA9-Pbx1-Meis1 activity, and progenitor transformation in collaboration with oncogenic K-Ras. Limiting HoxA9 alleles corrects, in a dose dependent manner, in vivo and in vitro phenotypes observed with loss of Gfi1 in myeloid progenitor cells, but did not rescue Gfi1-/- blocked granulopoiesis. Thus, Gfi1 integrates two events during normal myeloid differentiation; the suppression of a HoxA9-Pbx1-Meis1 progenitor program and the induction of a granulopoeitic transcription program.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||